Results of Danish Infliximab Biosimilar Switching Study Published

Published date16 May 2017
Law FirmGoodwin
Subject MatterClinical Trials,Prescription Drugs,Biosimilars,Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT